BDBM176676 US9115122, 2.3.2

SMILES c1ccc(cc1)S(=O)(=O)O[C@H]2CS(=O)(=O)C=C2

InChI Key InChIKey=RFHUNIXPGHBTTE-UHFFFAOYSA-N

Data  9 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 9 hits for monomerid = 176676   

TargetMitogen-activated protein kinase 1(Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  130nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [L114A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  27nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [Y191A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  130nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [R275A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  240nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [L265A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  280nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [L232A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  130nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [L235A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  90nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [L198A,L232A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd:  140nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1 [L198A,L235A](Mouse)
University of Maryland, Baltimore

US Patent
LigandPNGBDBM176676(US9115122, 2.3.2)
Affinity DataKd: >2.00E+4nMAssay Description:CADD and biological testing to identify compounds that interact with novel ERK substrate docking sites. The known ERK2 docking sites include the DRS ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2016
Entry Details
Go to US Patent